C

Celldex Therapeutics
D

CLDX

21.950
USD
-0.15
(-0.68%)
مغلق
حجم التداول
30,950
الربح لكل سهم
-3
العائد الربحي
-
P/E
-8
حجم السوق
1,457,353,590
أصول ذات صلة
A
ARVN
0.04000
(0.51%)
7.95000 USD
C
CRVS
-0.03500
(-0.88%)
3.95500 USD
F
FATE
0.02000
(1.80%)
1.13000 USD
MRNA
MRNA
0.195
(0.64%)
30.480 USD
N
NKTR
-0.740
(-2.90%)
24.775 USD
T
TGTX
0.670
(1.85%)
36.980 USD
المزيد
الأخبار المقالات

العنوان: Celldex Therapeutics

القطاع: Healthcare
الصناعة: Biotechnology
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.